BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 41435)

  • 21. Effects of 5-iodo-2'-deoxyuridine on ultrastructural localization of viral antigens in cultured cells infected with herpes simplex virus.
    Yoshida H; Sakata H; Hiyama N; Iwamoto T
    Jpn J Ophthalmol; 1983; 27(2):321-39. PubMed ID: 6312145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Syntheses of virus-induced thymidine kinase and viral DNA in herpes simplex type 1 virus-infected chick embryo fibroblasts.
    Roubal J; Závada V; Zelená D; Hirsch I
    Acta Virol; 1977 May; 21(3):177-83. PubMed ID: 18914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and characterization of herpes simplex virus resistant to nucleoside analogs.
    Katz E; Rosenblat O; Pisanty S
    Oral Surg Oral Med Oral Pathol; 1991 Sep; 72(3):296-9. PubMed ID: 1656355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative efficacy of three antiviral drugs in mice herpetic keratitis.
    Inoue Y; Ohashi Y; Shimomura Y; Manabe R; Yamada M; Ueda S; Kato S
    Jpn J Ophthalmol; 1989; 33(1):125-31. PubMed ID: 2543857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of therapeutic activity of idoxuridine and acyclovir in experimentally-induced herpetic keratitis in rabbits (author's transl)].
    Colin C; Chastel C; Quillien MC; Renard G
    J Fr Ophtalmol; 1981; 4(1):33-43. PubMed ID: 7217623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
    Schmit I; Boivin G
    J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potent activity of 5-fluoro-2'-deoxyuridine and related compounds against thymidine kinase-deficient (TK-) herpes simplex virus: targeted at thymidylate synthase.
    De Clercq E; Bères J; Bentrude WG
    Mol Pharmacol; 1987 Aug; 32(1):286-92. PubMed ID: 3039343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical resistance of herpetic keratitis to antiviral agents (author's transl)].
    Colin J; Chastel C; Baikoff G; Renard G
    J Fr Ophtalmol; 1981; 4(1):57-60. PubMed ID: 6260850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Herpes simplex virus stromal keratitis is not titer-dependent and does not correlate with neurovirulence.
    Grau DR; Visalli RJ; Brandt CR
    Invest Ophthalmol Vis Sci; 1989 Dec; 30(12):2474-80. PubMed ID: 2556353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo resistance of herpes simplex virus to 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine).
    Smith KO; Kennell WL; Poirier RH; Lynd FT
    Antimicrob Agents Chemother; 1980 Feb; 17(2):144-50. PubMed ID: 6247967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the development of resistant strains of Type 1 herpes simplex virus to in vitro antiviral activity of 5-iodo-2'-deoxyuridine or ribavirin.
    Huffman JH; Allen LB; Sidwell RW
    Ann N Y Acad Sci; 1977 Mar; 284(1):233-8. PubMed ID: 212974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine in the therapy of thymidine kinase-positive and -deficient herpes simplex virus experimental keratitis.
    Maudgal PC; De Clercq E
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1816-20. PubMed ID: 1851733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recovery of a latent HSV-1 thymidine kinase negative strain following iontophoresis and co-cultivation in the ocularly-infected rabbit model.
    Caudill JW; Romanowski E; Araullo-Cruz T; Gordon YJ
    Curr Eye Res; 1986 Jan; 5(1):41-5. PubMed ID: 3007031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HSV1 strain sensitivity in experimental rabbit keratitis: evolution under repeated topical IDU administrations.
    Denis J; Langlois M; Elkaim M; Amiel C; Aymard M; Huraux JM
    Curr Eye Res; 1987 Jan; 6(1):39-45. PubMed ID: 3030653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis.
    Maudgal PC; De Clercq E; Descamps J; Missotten L; De Somer P; Busson R; Vanderhaeghe H; Verhelst G; Walker RT; Jones AS
    Antimicrob Agents Chemother; 1980 Jan; 17(1):8-12. PubMed ID: 7352751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymidine kinase in IDU resistance.
    Centifanto Y; Kaufman HE
    Proc Soc Exp Biol Med; 1965 Oct; 120(1):23-6. PubMed ID: 4285237
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of trisodium phosphonoformate and idoxuridine on experimental herpes simplex keratitis in immunized and non-immunized rabbits.
    Alenius S; Laurent U; Oberg B
    Acta Ophthalmol (Copenh); 1980 Apr; 58(2):167-73. PubMed ID: 6249066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral drug sensitivity in ocular herpes simplex virus infection.
    Menage MJ; de Clercq E; van Lierde A; Easty VS; Darville JM; Cook SD; Easty DL
    Br J Ophthalmol; 1990 Sep; 74(9):532-5. PubMed ID: 2168202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herpes simplex virus types 1 and 2: therapeutic response to antiviral drugs.
    North RD; Pavan-Langston D; Geary P
    Arch Ophthalmol; 1976 Jun; 94(6):1019-21. PubMed ID: 180942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Light intensity on the photodynamic inactivation of herpes simplex keratitis.
    Stanley JA; Pinnolis M
    Am J Ophthalmol; 1976 Mar; 81(3):332-6. PubMed ID: 176890
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.